Comprehensive Stock Comparison
Compare Synopsys, Inc. (SNPS) vs MicroAlgo Inc. (MLGO) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | SNPS | 15.1% revenue growth vs MLGO's -9.2% |
| Value | MLGO | Lower P/E (6.5x vs 28.7x) |
| Quality / Margins | SNPS | 13.8% net margin vs MLGO's 11.1% |
| Stability / Safety | MLGO | Beta 0.16 vs SNPS's 1.37, lower leverage |
| Dividends | Tie | Neither pays a meaningful dividend |
| Momentum (1Y) | SNPS | -9.5% vs MLGO's -97.1% |
| Efficiency (ROA) | SNPS | 2.3% ROA vs MLGO's 2.1%, ROIC 3.0% vs 14.1% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
Synopsys is a leading provider of electronic design automation software and semiconductor intellectual property used to design and test integrated circuits. The company generates revenue primarily from software license sales (~60% of revenue) and maintenance/services (~40%), with its IP segment—which includes interface, analog, and security IP—growing rapidly. Its competitive moat stems from deep technical expertise, long-standing customer relationships in the complex semiconductor design ecosystem, and high switching costs for its mission-critical tools.
MicroAlgo develops central processing algorithm solutions that optimize computing performance for clients in internet advertising, gaming, and intelligent chips. It generates revenue primarily through algorithm services — including optimization, data processing, and intelligence services — and secondarily through intelligent chip resale and software development. The company's competitive advantage lies in its proprietary algorithms that accelerate computing power without requiring hardware upgrades, offering cost-effective performance enhancements.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
SNPS leads in 2 of 6 categories (Financial Metrics, Total Returns). MLGO leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.
Financial Metrics (TTM)
SNPS is the larger business by revenue, generating $8.0B annually — 130.9x MLGO's $61M. Profitability is closely matched — net margins range from 13.8% (SNPS) to 11.1% (MLGO). On growth, SNPS holds the edge at +65.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | SNPSSynopsys, Inc. | MLGOMicroAlgo Inc. |
|---|---|---|
| RevenueTrailing 12 months | $8.0B | $61M |
| EBITDAEarnings before interest/tax | $1.7B | $4M |
| Net IncomeAfter-tax profit | $1.1B | $7M |
| Free Cash FlowCash after capex | $2.3B | $9M |
| Gross MarginGross profit ÷ Revenue | +75.1% | +26.8% |
| Operating MarginEBIT ÷ Revenue | +10.8% | +5.8% |
| Net MarginNet income ÷ Revenue | +13.8% | +11.1% |
| FCF MarginFCF ÷ Revenue | +28.5% | +14.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +65.5% | -34.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -78.8% | -8.2% |
Valuation Metrics
At 6.5x trailing earnings, MLGO trades at a 87% valuation discount to SNPS's 51.5x P/E.
| Metric | SNPSSynopsys, Inc. | MLGOMicroAlgo Inc. |
|---|---|---|
| Market CapShares × price | $79.3B | $36M |
| Enterprise ValueMkt cap + debt − cash | $90.7B | -$85M |
| Trailing P/EPrice ÷ TTM EPS | 51.49x | 6.49x |
| Forward P/EPrice ÷ next-FY EPS est. | 28.67x | — |
| PEG RatioP/E ÷ EPS growth rate | 3.82x | — |
| EV / EBITDAEnterprise value multiple | 57.55x | -30.45x |
| Price / SalesMarket cap ÷ Revenue | 11.24x | 0.48x |
| Price / BookPrice ÷ Book value/share | 2.36x | 0.23x |
| Price / FCFMarket cap ÷ FCF | 58.75x | 8.77x |
Profitability & Efficiency
SNPS delivers a 3.6% return on equity — every $100 of shareholder capital generates $4 in annual profit, vs $2 for MLGO. MLGO carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to SNPS's 0.50x. On the Piotroski fundamental quality scale (0–9), MLGO scores 4/9 vs SNPS's 3/9, reflecting mixed financial health.
| Metric | SNPSSynopsys, Inc. | MLGOMicroAlgo Inc. |
|---|---|---|
| ROE (TTM)Return on equity | +3.6% | +2.1% |
| ROA (TTM)Return on assets | +2.3% | +2.1% |
| ROICReturn on invested capital | +3.0% | +14.1% |
| ROCEReturn on capital employed | +3.3% | +2.9% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 |
| Debt / EquityFinancial leverage | 0.50x | 0.16x |
| Net DebtTotal debt minus cash | $11.4B | -$121M |
| Cash & Equiv.Liquid assets | $2.9B | $144M |
| Total DebtShort + long-term debt | $14.3B | $23M |
| Interest CoverageEBIT ÷ Interest expense | 6.38x | 25.26x |
Total Returns (with DRIP)
A $10,000 investment in SNPS five years ago would be worth $16,288 today (with dividends reinvested), compared to $1 for MLGO. Over the past 12 months, SNPS leads with a -9.5% total return vs MLGO's -97.1%. The 3-year compound annual growth rate (CAGR) favors SNPS at 4.4% vs MLGO's -93.3% — a key indicator of consistent wealth creation.
| Metric | SNPSSynopsys, Inc. | MLGOMicroAlgo Inc. |
|---|---|---|
| YTD ReturnYear-to-date | -13.8% | -30.3% |
| 1-Year ReturnPast 12 months | -9.5% | -97.1% |
| 3-Year ReturnCumulative with dividends | +13.8% | -100.0% |
| 5-Year ReturnCumulative with dividends | +62.9% | -100.0% |
| 10-Year ReturnCumulative with dividends | +825.1% | -100.0% |
| CAGR (3Y)Annualised 3-year return | +4.4% | -93.3% |
Risk & Volatility
MLGO is the less volatile stock with a 0.16 beta — it tends to amplify market swings less than SNPS's 1.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SNPS currently trades 63.5% from its 52-week high vs MLGO's 0.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | SNPSSynopsys, Inc. | MLGOMicroAlgo Inc. |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.37x | 0.16x |
| 52-Week HighHighest price in past year | $651.73 | $972.00 |
| 52-Week LowLowest price in past year | $365.74 | $3.35 |
| % of 52W HighCurrent price vs 52-week peak | +63.5% | +0.4% |
| RSI (14)Momentum oscillator 0–100 | 42.9 | 41.8 |
| Avg Volume (50D)Average daily shares traded | 1.7M | 149K |
Analyst Outlook
| Metric | SNPSSynopsys, Inc. | MLGOMicroAlgo Inc. |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — |
| Price TargetConsensus 12-month target | $529.44 | — |
| # AnalystsCovering analysts | 27 | — |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | May 21 | Feb 26 | Change |
|---|---|---|---|
| Synopsys, Inc. (SNPS) | 100 | 187.04 | +87.0% |
| MicroAlgo Inc. (MLGO) | 102.37 | 0.01 | -100.0% |
Synopsys, Inc. (SNPS) returned +63% over 5 years vs MicroAlgo Inc. (MLGO)'s -100%. A $10,000 investment in SNPS 5 years ago would be worth $16,288 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Synopsys, Inc. (SNPS) | $2.4B | $7.1B | +191.2% |
| MicroAlgo Inc. (MLGO) | $16M | $74M | +364.6% |
Synopsys, Inc.'s revenue grew from $2.4B (2016) to $7.1B (2025) — a 12.6% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Synopsys, Inc. (SNPS) | 11.0% | 18.9% | +71.5% |
| MicroAlgo Inc. (MLGO) | 39.0% | 7.1% | -81.7% |
Synopsys, Inc.'s net margin went from 11% (2016) to 19% (2025).
Chart 4P/E Ratio History — 9 Years
| Stock | 2017 | 2025 | Change |
|---|---|---|---|
| Synopsys, Inc. (SNPS) | 96.9 | 58.4 | -39.7% |
Synopsys, Inc. has traded in a 30x–97x P/E range over 9 years; current trailing P/E is ~51x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Synopsys, Inc. (SNPS) | 1.73 | 8.04 | +364.7% |
| MicroAlgo Inc. (MLGO) | 29.45 | 0.55 | -98.1% |
Synopsys, Inc.'s EPS grew from $1.73 (2016) to $8.04 (2025) — a 19% CAGR.
Chart 6Free Cash Flow — 5 Years
Synopsys, Inc. generated $1B FCF in 2025 (-3% vs 2021). MicroAlgo Inc. generated $4M FCF in 2024 (-74% vs 2021).
SNPS vs MLGO: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is SNPS or MLGO a better buy right now?
MicroAlgo Inc. (MLGO) offers the better valuation at 6.5x trailing P/E, making it the more compelling value choice. Analysts rate Synopsys, Inc. (SNPS) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SNPS or MLGO?
On trailing P/E, MicroAlgo Inc. (MLGO) is the cheapest at 6.5x versus Synopsys, Inc. at 51.5x.
03Which is the better long-term investment — SNPS or MLGO?
Over the past 5 years, Synopsys, Inc. (SNPS) delivered a total return of +62.9%, compared to -100.0% for MicroAlgo Inc. (MLGO). A $10,000 investment in SNPS five years ago would be worth approximately $16K today (assuming dividends reinvested). Over 10 years, the gap is even starker: SNPS returned +825.1% versus MLGO's -100.0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SNPS or MLGO?
By beta (market sensitivity over 5 years), MicroAlgo Inc. (MLGO) is the lower-risk stock at 0.16β versus Synopsys, Inc.'s 1.37β — meaning SNPS is approximately 772% more volatile than MLGO relative to the S&P 500. On balance sheet safety, MicroAlgo Inc. (MLGO) carries a lower debt/equity ratio of 16% versus 50% for Synopsys, Inc. — giving it more financial flexibility in a downturn.
05Which has better profit margins — SNPS or MLGO?
Synopsys, Inc. (SNPS) is the more profitable company, earning 18.9% net margin versus 7.1% for MicroAlgo Inc. — meaning it keeps 18.9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SNPS leads at 13.0% versus 3.7% for MLGO. At the gross margin level — before operating expenses — SNPS leads at 77.0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — SNPS or MLGO?
None of the stocks in this comparison currently pay a material dividend. All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is SNPS or MLGO better for a retirement portfolio?
For long-horizon retirement investors, MicroAlgo Inc. (MLGO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.16)). Both have compounded well over 10 years (MLGO: -100.0%, SNPS: +825.1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between SNPS and MLGO?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. In terms of investment character: SNPS is a mid-cap quality compounder stock; MLGO is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.